Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
Attending:	O
___	O
___	O
Complaint:	O
Dilated	O
common	O
bile	O
duct	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
ERCP	O
History	O
of	O
Present	O
Illness:	O
___	O
yoF	O
with	O
h/o	O
CAD,	O
HTN,	O
HL,	O
renal	O
cell	O
carcinoma	O
and	O
CKD	O
who	O
presents	O
after	O
ERCP.	O
She	O
was	O
hospitalized	O
in	O
___	O
for	O
BRBPR.	B-Lower_gastrointestinal_haemorrhage
At	O
that	O
time,	O
she	O
was	O
incidentally	O
found	O
to	O
have	O
a	O
dilated	O
common	O
bile	O
duct	O
to	O
21mm.	O
She	O
then	O
underwent	O
outpatient	O
EUS	O
in	O
___	O
which	O
showed	O
a	O
dilated	O
CBD	O
to	O
10mm	O
and	O
ERCP	O
was	O
recomended	O
for	O
further	O
evaluation.	O
Today	O
she	O
went	O
for	O
ERCP	O
which	O
showed	O
a	O
12mm	O
CBD	O
without	O
filling	O
defect.	O
Also	O
found	O
to	O
have	O
stenotic	O
papilla	O
and	O
sphincterotomy	O
was	O
performed.	O
Balloon	O
sweeps	O
were	O
done	O
with	O
extraction	O
of	O
sludge.	O
Currently,	O
she	O
reports	O
mild	O
nausea	O
and	O
vomited	O
x	O
1	O
after	O
the	O
procedure.	O
Denies	O
abdominal	O
pain.	O
Reports	O
she	O
has	O
felt	O
well	O
at	O
home	O
recently	O
without	O
any	O
abdominal	O
pain,	O
nausea,	O
vomiting,	O
diarrhea,	O
or	O
constipation.	B-Constipation
REVIEW	O
OF	O
SYSTEMS:	O
Denies	O
fever,	O
chills,	O
night	O
sweats,	O
headache,	O
vision	B-Visual_impairment
changes,	B-Visual_impairment
rhinorrhea,	O
congestion,	O
sore	O
throat,	O
cough,	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
abdominal	O
pain,	O
nausea,	O
vomiting,	O
diarrhea,	O
constipation,	B-Constipation
BRBPR,	B-Lower_gastrointestinal_haemorrhage
melena,	B-Upper_gastrointestinal_haemorrhage
hematochezia,	B-Lower_gastrointestinal_haemorrhage
dysuria,	O
hematuria.	O
All	O
other	O
10-system	O
review	O
negative	O
in	O
detail.	O
Past	O
Medical	O
History:	O
CAD	O
s/p	O
NSTEMI	O
___,	O
medically	O
managed	O
COPD	O
CKD,	O
stage	O
III	O
Renal	O
cell	O
carcinoma	O
H/o	O
respiratory	O
failure	O
___	O
requiring	O
trach	O
placement	O
Hyponatremia	O
Colonic	O
polyps	O
___	O
Hypercholesterolemia	O
Hypertension	O
Lobular	O
carcinoma	O
in	O
situ	O
___	O
Osteoporosis	O
___	O
Overactive	O
bladder	O
UTI	B-Urinary_tract_infection
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
had	O
HTN,	O
mother	O
died	O
at	O
___.	O
Physical	O
Exam:	O
VS:	O
97.2	O
62	O
119/52	O
18	O
97%RA	O
GEN:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress	O
HEENT:	O
NCAT	O
MMM	O
EOMI,	O
sclera	O
anicteric,	O
OP	O
clear	O
NECK:	O
supple,	O
no	O
JVD	O
PULM:	O
CTAB	O
without	O
wheezes,	O
rales,	O
ronchi	O
CV:	O
RRR	O
normal	O
S1/S2,	O
no	O
mrg	O
ABD:	O
Soft,	O
NT,	O
ND,	O
bowel	O
sounds	O
present,	O
no	O
r/g	O
EXT:	O
WWP	O
2+	O
pulses	O
palpable	O
bilaterally,	O
no	O
c/c/e	O
SKIN:	O
no	O
ulcers	B-Pressure_injury
or	O
lesions	O
O2	O
sat	O
at	O
time	O
of	O
discharge:	O
93%RA	O
Pertinent	O
Results:	O
___	O
06:05AM	O
BLOOD	O
WBC-10.7	O
RBC-4.07*	O
Hgb-12.2	O
Hct-34.8*	O
MCV-86	O
MCH-30.0	O
MCHC-35.1*	O
RDW-13.5	O
Plt	O
___	O
___	O
06:05AM	O
BLOOD	O
Neuts-81.9*	O
Lymphs-11.2*	O
Monos-5.5	O
Eos-1.1	O
Baso-0.2	O
___	O
06:05AM	O
BLOOD	O
Glucose-88	O
UreaN-14	O
Creat-1.1	O
Na-139	O
K-3.9	O
Cl-100	O
HCO3-29	O
AnGap-14	O
___	O
06:05AM	O
BLOOD	O
ALT-17	O
AST-23	O
AlkPhos-75	O
TotBili-0.6	O
___	O
06:05AM	O
BLOOD	O
Calcium-9.4	O
Phos-3.8	O
Mg-1.6	O
___	O
CT	O
abd/pelvis:	O
1.	O
No	O
evidence	O
of	O
active	O
arterial	O
extravasation.	O
2.	O
Diverticulosis	O
without	O
diverticulitis.	O
3.	O
Intra-	O
and	O
extra-hepatic	O
bile	O
duct	O
dilation	O
with	O
CBD	O
dilation	O
to	O
21-mm	O
is	O
new	O
from	O
___.	O
4.	O
Enlarging	O
enhancing	O
left	O
renal	O
lesion	O
is	O
concerning	O
for	O
renal	O
cell	O
carcinoma.	O
___	O
EUS:	O
The	O
ampulla	O
was	O
viewed	O
with	O
the	O
linear	O
echoendoscope	O
and	O
was	O
normal.	O
EUS:	O
The	O
common	O
bile	O
duct	O
was	O
dilated	O
to	O
at	O
least	O
1cm	O
although	O
EUS	O
can	O
understimate	O
CBD	O
diameter.	O
Within	O
the	O
distal	O
CBD	O
there	O
was	O
a	O
small	O
non-shadowing	O
filling	O
defect	O
within	O
the	O
duct	O
that	O
measured	O
4.1	O
mm	O
in	O
one	O
plane.	O
This	O
could	O
be	O
consistent	O
with	O
a	O
CBD	O
polyp	O
versus	O
a	O
tortuous	O
S-shaped	O
distal	O
common	O
bile	O
duct.	O
The	O
pancreas	O
was	O
normal	O
in	O
the	O
head.	O
It	O
was	O
hyperechoic	O
in	O
the	O
body	O
and	O
tail	O
consistent	O
with	O
fatty	O
pancreas.	O
The	O
pancreatic	O
duct	O
was	O
normal	O
and	O
nondilated.	O
The	O
ampulla	O
was	O
normal.	O
The	O
visualized	O
liver	O
(left	O
lobe)	O
was	O
normal.	O
No	O
___,	O
porta	O
hepatis,	O
gastro-hepatic	O
or	O
celiac	O
lymphadenopathy	O
was	O
seen.	O
Otherwise	O
normal	O
upper	O
eus	O
to	O
second	O
part	O
of	O
the	O
duodenum	O
Recommendations:	O
Given	O
EUS	O
findings,	O
recommend	O
ERCP	O
for	O
further	O
evaluation.	O
___	O
ERCP:	O
Normal	O
major	O
papilla	O
Cannulation	O
of	O
the	O
biliary	O
duct	O
was	O
successful	O
and	O
deep	O
with	O
a	O
sphincterotome	O
using	O
a	O
free-hand	O
technique.	O
Dilatation	O
of	O
the	O
CBD	O
to	O
12mm	O
and	O
mild	O
dilatation	O
of	O
the	O
main	O
intrahepatic	O
bile	O
ducts.	O
No	O
filling	O
defect	O
in	O
the	O
CBD.	O
Sphincterotomy	O
and	O
balloon	O
sweeps	O
with	O
extraction	O
of	O
sludge.	O
The	O
dilatation	O
of	O
the	O
biliary	O
tree	O
was	O
probably	O
due	O
to	O
a	O
long	O
intraduodenal	O
segment	O
of	O
the	O
papilla	O
which	O
was	O
somewhat	O
stenotic.	O
Otherwise	O
normal	O
ercp	O
to	O
third	O
part	O
of	O
the	O
duodenum.	O
___	O
CXR:	O
In	O
comparison	O
with	O
study	O
of	O
___,	O
there	O
are	O
somewhat	O
lower	O
lung	O
volumes.	O
Some	O
coarse	O
interstitial	O
markings	O
are	O
seen	O
at	O
the	O
bases	O
and	O
there	O
is	O
again	O
flattening	O
of	O
the	O
hemidiaphragms,	O
all	O
consistent	O
with	O
chronic	O
pulmonary	O
disease.	O
No	O
definite	O
acute	O
focal	O
pneumonia	B-Lower_respiratory_tract_infection
or	O
vascular	O
congestion.	O
Brief	O
Hospital	O
Course:	O
___	O
yoF	O
with	O
h/o	O
CAD,	O
HTN,	O
HL,	O
renal	O
cell	O
carcinoma	O
and	O
CKD	O
who	O
presents	O
after	O
ERCP,	O
found	O
to	O
have	O
common	O
bile	O
duct	O
dilation.	O
#	O
CBD	O
dilation:	O
Found	O
to	O
have	O
a	O
dilated	O
common	O
bile	O
duct	O
on	O
ERCP,	O
likely	O
related	O
to	O
stenosis	O
of	O
papilla.	O
She	O
had	O
sphincterotomy	O
performed	O
without	O
complication.	O
She	O
was	O
kept	O
NPO	O
overnight	O
and	O
diet	O
was	O
advanced	O
without	O
complication.	O
At	O
the	O
time	O
of	O
discharge	O
she	O
was	O
tolerating	O
a	O
regular	O
diet.	O
#	O
Hypoxemia:	O
The	O
day	O
after	O
her	O
ERCP	O
she	O
developed	O
hypoxemia	O
to	O
the	O
high	O
80's	O
on	O
room	O
air,	O
which	O
improved	O
with	O
___	O
O2.	O
She	O
remained	O
asymptomatic.	O
CXR	O
showed	O
chronic	O
pulmonary	O
changes	O
without	O
acute	O
process.	O
Given	O
that	O
her	O
hypoxia	O
developed	O
after	O
receiving	O
aggressive	O
IV	O
fluids	O
after	O
ERCP,	O
she	O
was	O
given	O
a	O
dose	O
of	O
lasix	O
and	O
her	O
hypoxia	O
improved	O
somewhat.	O
She	O
was	O
93%	O
on	O
room	O
air	O
at	O
the	O
time	O
of	O
discharge	O
and	O
remained	O
asymptomatic.	O
She	O
should	O
follow-up	O
with	O
her	O
PCP	O
for	O
recheck	O
and	O
potentially	O
further	O
workup	O
of	O
her	O
lung	O
disease.	O
She	O
does	O
have	O
a	O
history	O
of	O
COPD	O
but	O
had	O
no	O
wheezing	O
on	O
exam.	O
She	O
was	O
kept	O
on	O
her	O
home	O
COPD	O
meds.	O
#	O
Renal	O
cell	O
carcinoma:	O
Managed	O
expectantly	O
as	O
outpatient.	O
Should	O
have	O
urology	O
follow-up	O
#	O
CAD:	O
s/p	O
NSTEMI	O
___,	O
medically	O
managed:	O
Recently	O
seen	O
by	O
cardiology,	O
no	O
longer	O
on	O
Plavix	O
given	O
recent	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed.	B-Upper_gastrointestinal_haemorrhage
Held	O
aspirin	O
during	O
this	O
admission	O
given	O
her	O
sphincterotomy,	O
but	O
it	O
can	O
be	O
restarted	O
in	O
5	O
days	O
Continued	O
her	O
home	O
beta	O
blocker,	O
ACE,	O
and	O
statin.	O
#	O
HTN:	O
Continued	O
home	O
ACE,	O
BB,	O
CCB.	O
Thiazide	O
was	O
held	O
during	O
this	O
admission	O
and	O
restarted	O
at	O
discharge.	O
#	O
CKD:	O
Recent	O
baseline	O
creatinine	O
1.3,	O
was	O
1.1	O
on	O
this	O
admission.	O
#	O
Osteoporosis:	O
Given	O
calcium/vitamin	O
D	O
#	O
GERD:	O
Home	O
ranitidine	O
#	O
Anemia:	O
Home	O
iron	O
#	O
Hyperlipidemia:	O
Continued	O
home	O
statin	O
CODE:	O
Full	O
code,	O
confirmed	O
EMERGENCY	O
CONTACT:	O
HCP	O
is	O
husband	O
___	O
(___),	O
secondary	O
is	O
daughter	O
___	O
___	O
or	O
___	O
Transitional	O
Issues:	O
-	O
Should	O
have	O
O2	O
sat/ambulatory	O
sat	O
checked	O
as	O
an	O
outpatient	O
and	O
consideration	O
of	O
further	O
evaluation	O
of	O
her	O
lung	O
disease	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Albuterol	O
Inhaler	O
1	O
PUFF	O
IH	O
Q4H:PRN	O
SOB,	O
wheeze	O
2.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
40	O
mg	O
PO	O
DAILY	O
4.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
BID	O
5.	O
Vitamin	O
D	O
800	O
UNIT	O
PO	O
DAILY	O
6.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
7.	O
Fluticasone-Salmeterol	O
Diskus	O
(250/50)	O
2	O
puffs	O
IH	O
BID	O
8.	O
Lisinopril	O
30	O
mg	O
PO	O
DAILY	O
9.	O
Metoprolol	O
Succinate	O
XL	O
150	O
mg	O
PO	O
BID	O
10.	O
Ranitidine	O
300	O
mg	O
PO	O
DAILY	O
11.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
12.	O
traZODONE	O
75	O
mg	O
PO	O
HS:PRN	O
insomnia	O
Discharge	O
Medications:	O
1.	O
Albuterol	O
Inhaler	O
1	O
PUFF	O
IH	O
Q4H:PRN	O
SOB,	O
wheeze	O
2.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
40	O
mg	O
PO	O
DAILY	O
4.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
BID	O
5.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
6.	O
Fluticasone-Salmeterol	O
Diskus	O
(250/50)	O
2	O
puffs	O
IH	O
BID	O
7.	O
Lisinopril	O
30	O
mg	O
PO	O
DAILY	O
8.	O
Metoprolol	O
Succinate	O
XL	O
150	O
mg	O
PO	O
BID	O
9.	O
Ranitidine	O
300	O
mg	O
PO	O
DAILY	O
10.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
11.	O
traZODONE	O
75	O
mg	O
PO	O
HS:PRN	O
insomnia	O
12.	O
Vitamin	O
D	O
800	O
UNIT	O
PO	O
DAILY	O
13.	O
Chlorthalidone	O
12.5	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary	O
Diagnosis:	O
Common	O
bile	O
duct	O
dilation	O
due	O
to	O
papillary	O
stenosis	O
Hypoxemia	O
Secondary	O
Diagnosis:	O
CAD	O
COPD	O
Renal	O
cell	O
carcinoma	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
after	O
ERCP	O
for	O
monitoring.	O
Your	O
ERCP	O
was	O
uncomplicated	O
and	O
you	O
were	O
found	O
to	O
have	O
a	O
stenosis	O
(narrowing)	O
of	O
your	O
biliary	O
duct	O
which	O
was	O
treated	O
with	O
a	O
procedure	O
called	O
a	O
sphincterotomy	O
to	O
open	O
up	O
the	O
narrowing.	O
You	O
tolerated	O
the	O
procedure	O
well	O
without	O
complications.	O
You	O
were	O
tolerating	O
a	O
regular	O
diet	O
at	O
the	O
time	O
of	O
discharge.	O
The	O
oxygen	O
level	O
in	O
your	O
blood	O
was	O
also	O
found	O
to	O
be	O
low	O
after	O
the	O
procedure	O
and	O
you	O
were	O
kept	O
in	O
the	O
hospital	O
for	O
this	O
reason.	O
It	O
improved	O
by	O
the	O
time	O
of	O
discharge.	O
It	O
is	O
important	O
that	O
you	O
weigh	O
yourself	O
every	O
morning,	O
and	O
call	O
your	O
primary	O
care	O
doctor	O
if	O
your	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
Followup	O
Instructions:	O
___	O

